Stockreport

Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat [Yahoo! Finance]

Agios Pharmaceuticals, Inc.  (AGIO) 
Last agios pharmaceuticals, inc. earnings: 4/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.agios.com/investor-overview
PDF The study found that mitapivat significantly reduced transfusion burden compared to placebo, meeting its primary endpoint. The results also showed that mitapivat demonst [Read more]